The exercise-and-sell transaction came as the rare disease drugmaker reported strong quarterly results. Jeffrey Del Carmen, Chief Commercial Officer of Catalyst Pharmaceuticals (CPRX +0.26%), exercised and immediately sold 10,983 shares of common stock on November 26, 2025, for a total value of approximately $256,200, as disclosed in this SEC Form 4 filing.Transaction summaryMetricValueShares sold10,983Transaction value~$256,200Post-transaction shares3,962Post-transaction value (direct ownership)~$92,800Tra ...